• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD MULTI-CHECK CONTROL 2X2.5ML IVD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD MULTI-CHECK CONTROL 2X2.5ML IVD Back to Search Results
Model Number 340912
Device Problem Low Readings (2460)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/01/2020
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that while using bd multi-check control 2x2.5ml ivd the cd4 events are not within range.The following information was provided by the initial reporter: the customer is reporting the % of cd4 events is not within the ranges stated for this lot.
 
Manufacturer Narrative
The following fields have been updated with corrected information: d.1 medical device type: na.G.5.Pma / 510(k)#: na.
 
Event Description
It was reported that while using bd multi-check control 2x2.5ml ivd the cd4 events are not within range.The following information was provided by the initial reporter: the customer is reporting the % of cd4 events is not within the ranges stated for this lot.
 
Manufacturer Narrative
H.6.Investigation: problem statement: customer reported complaint on bd multi-check control ivd having issues with the percent of cd4 events not within the range reported on reagent material # 3409127 lot# bm1120n on 04dec2020.Scope.The scope of issue is limited to part 340912 and lot bm1120n.Manufacturing defect trend: this product is manufactured by a third party.Manufacturing non-conformance data are not routinely available.Complaint trend: there is one complaint related to the reported complaint for the date range between (b)(6) 2019 and (b)(6) 2020.Batch history record (bhr) review: documentation for part 340912 and lot bm1120n was reviewed.The materials were found to have met all the manufacturing specifications prior to release.Retain sample evaluation / testing: the retain sample for part 340912, lot bm1120 was not tested prior to product expiry.Exp.Date 02dec2020.Returned sample evaluation: the sample was not requested to be returned because of product expiration.Exp.Date 02dec2020.Investigation result / analysis: the investigation was performed and based on the review of complaint trend, defect trend, bhr, root cause and risk analysis, the reported complaint was not confirmed.Risk analysis: hazard(s) identified? yes if no (to above), what actions will be taken? hazard #: _3.1.2 ¿ 3.2.3____.Hazard:_ _use error hazard___.Cause:_instability / improper storage / contamination _.Harmful effects: incorrect results, per assay value sheet, leads to a delay in results.Severity: __4____.Probability: __2___.Risk index: _8_____.Implementation: _in use stability study protocols; manufacturing procedures; qc testing protocols; ifu.___ risk control: _the design and development of the device will ensure that the process control works appropriately.All batches will be qc tested to ensure device is performing as intended; the ifu will provide instructions on how to properly use the device as intended; coa with incoming product at bd; qc testing results at supplier¿s.Effectiveness verification: _shelf life stability report; label approval process; _ new hazard: _no_.Mitigation(s) sufficient _yes__.Root cause analysis: based on the investigation result, root cause was not determined.Investigation conclusion: based on the investigation result, complaint was not confirmed.
 
Event Description
It was reported that while using bd multi-check control 2x2.5ml ivd the cd4 events are not within range.The following information was provided by the initial reporter: the customer is reporting the % of cd4 events is not within the ranges stated for this lot.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MULTI-CHECK CONTROL 2X2.5ML IVD
Type of Device
NA
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
MDR Report Key11098494
MDR Text Key234293691
Report Number2916837-2020-00333
Device Sequence Number1
Product Code GKZ
UDI-Device Identifier00382903409129
UDI-Public00382903409129
Combination Product (y/n)N
PMA/PMN Number
K961610
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup,Followup
Report Date 06/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/30/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date12/02/2020
Device Model Number340912
Device Catalogue Number340912
Device Lot NumberBM1120N
Was Device Available for Evaluation? No
Date Manufacturer Received06/21/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-